News Release

<< Back
View printer-friendly version
05/04/07
USEC Reports First Quarter 2007 Results
    --  $39.3 million net income for first quarter 2007 compared with
        $34.6 million in first quarter 2006

    --  As anticipated, gross profit margin falls from same quarter
        last year

    --  2007 guidance updated

    --  Initial American Centrifuges being assembled and installed for
        Lead Cascade; operations expected in mid-2007

BETHESDA, Md.--(BUSINESS WIRE)--May 4, 2007--USEC Inc. (NYSE:USU) today reported net income of $39.3 million or 45 cents per share in the first quarter ended March 31, 2007 compared to $34.6 million or 40 cents per share in the same quarter of 2006. Pro forma net income before American Centrifuge expenses was $61.0 million in the first quarter of 2007, compared to $47.3 million in the same period last year.

The improved year-over-year financial results reflect the impact of approximately $16.9 million of non-cash reversals of prior income tax-related accruals. The gross profit margin fell to 15.7 percent from 25.5 percent in the same quarter last year, as higher revenue in 2007 was offset by the increasing impact of higher electric power costs and higher purchase costs from Russia.

"In line with the guidance we have been providing since last summer, USEC's gross profit margin declined substantially in the first quarter as the higher cost of electric power for the Paducah plant works through our SWU inventory," said John K. Welch, president and chief executive officer.

"Spending on American Centrifuge was higher, reflecting our work to prepare the Piketon facility for commercial plant construction and to assemble and install the first American Centrifuge machines that will make up the Lead Cascade. We are on track to begin Lead Cascade operations in mid-2007 and meet our revised performance milestone with the Department of Energy," he added.

USEC currently expenses most of its spending related to the American Centrifuge, which directly reduces net income. To help investors evaluate the impact of these adjustments to current business results, USEC is reporting a non-GAAP financial measure - pro forma net income before American Centrifuge expenses. A table reconciling this measure to net income is included in this news release.

Revenue

Revenue for the first quarter was $465.0 million, an increase of $103.7 million over the same period in 2006. Revenue from the sales of SWU was $405.0 million, compared to $234.0 million in the first quarter of 2006. The $171.0 million improvement reflects a 56 percent increase in volume of separative work units (SWU) sold and an 11 percent increase in average prices billed to customers. Uranium revenue was $15.8 million compared to $75.8 million last year, reflecting a limited number of deliveries this year. Revenue from our U.S. government contracts segment was $44.2 million compared to $51.5 million in the prior year, reflecting reduced DOE and other contract work, and lower revenue from subsidiary NAC International.

At March 31, 2007, deferred revenue amounted to $146.2 million, with a deferred gross profit of $73.6 million compared to deferred revenue at year-end 2006 of $129.4 million with a deferred gross profit of $51.0 million. In a number of sales transactions, USEC transfers title and collects cash from customers but does not recognize the revenue until low enriched uranium is physically delivered.

Cost of Sales, Gross Profit Margin and Expenses

Cost of sales in the first quarter for SWU and uranium was $353.2 million, an increase of $127.5 million or 56 percent due to an increase in SWU sales volume and SWU and uranium unit costs. Cost of sales for SWU reflects monthly moving average inventory costs based on production and purchase costs. The unit cost of sales per SWU during the quarter was 8 percent higher than the year before, reflecting a 44 percent increase in production costs per SWU due to higher power costs and higher purchase prices paid to Russia. Purchase prices paid to Russia are set by a market-based pricing formula and have increased as market prices have increased in recent years. Cost of sales for U.S. government contracts was $38.6 million, a reduction of $5.0 million or 11 percent compared to the same quarter last year.

Our cost of sales increased during the first quarter and will continue to increase during 2007 as a result of a greater than 50 percent increase in the price USEC pays for electric power used by the gaseous diffusion plant in Paducah, Kentucky. The cost of electric power increased $55.4 million compared to the first quarter of 2006. The higher prices went into effect in June 2006 as part of a one-year pricing agreement signed with the Tennessee Valley Authority (TVA), which supplies all of the power for the Paducah plant. The impact of this increase is only now being fully realized and increased power prices will put significant pressure on our gross profit margin this year and beyond. USEC is currently negotiating with TVA regarding power prices beyond May 31, 2007. The Company is looking to moderate the previous price increase and contract for additional power. We are also discussing the possibility of a multi-year agreement to provide additional stability. However, USEC may not achieve these desired results, and regardless of what we are able to negotiate, we expect the high cost of power to continue to adversely affect the gross profit margin until the American Centrifuge Plant is complete.

The gross profit for the first quarter 2007 was $73.2 million, a decline of $18.8 million or 20 percent over the same period in 2006. The gross profit margin for the quarter was 15.7 percent compared to 25.5 percent in the same period last year. USEC expects the gross margin to decline further as the year progresses due to higher electric power costs and a decrease in uranium volume sold.

Selling, general and administrative (SG&A) expenses totaled $12.5 million, an increase of $0.8 million over first quarter 2006. In the 2006 period, there was a credit for a change in a long-term incentive compensation program, partially offset by higher expense for leased office space that USEC ceased using at that time.

Advanced technology expenses, primarily related to the demonstration of the American Centrifuge technology, were $33.7 million in the first quarter, an increase of $13.9 million compared to the same period of 2006. The first quarter 2007 results of operations include an out-of-period adjustment that decreased advanced technology costs by approximately $3.0 million attributed to a vendor refund. Spending by NAC on its spent fuel storage technology is included in the total and was $0.3 million in both periods. In addition, $13.5 million in spending related to the commercial American Centrifuge Plant was capitalized in the quarter, compared to $5.6 million capitalized in the first quarter of 2006.

Cash Flow

At March 31, 2007, USEC had a cash balance of $238.6 million, compared to $171.4 million at December 31, 2006 and $21.6 million at March 31, 2006. Cash flow from operations in the first quarter generated $87.5 million, compared to $37.1 million in the corresponding period in 2006. The $50.4 million difference was primarily due to timing of payments to Russia under the Megatons to Megawatts program and higher customer collections where revenue and earnings are deferred until delivery.

Capital expenditures totaled $16.1 million for the first quarter, compared to $7.5 million for the corresponding period of 2006. The majority of capital expenditures were related to the American Centrifuge project, as noted above.

2007 Outlook Update

USEC has updated its earnings guidance for 2007 to reflect the impacts of approximately $16.9 million of non-cash reversals of prior income tax-related accruals. The Company now expects net income to be approximately breakeven for the full year based on these reversals. The Company reiterates its previous guidance provided in its Form 10-K for cash flow from operations in 2007 of negative $65 to $75 million. The Company also reiterates its previous guidance for revenue, cost of sales, gross profit margin and American Centrifuge spending. The prior guidance contained a number of assumptions and uncertainties that could affect results positively or negatively, and those factors are also reiterated.

American Centrifuge Update

USEC continues to make progress in its demonstration and deployment of the American Centrifuge technology. In recent months:

    --  The U.S. Nuclear Regulatory Commission issued a construction
        and operating license for the American Centrifuge Plant on
        April 13, 2007. The license is for a 30-year period and allows
        us to begin construction on the commercial plant that we
        anticipate will provide about 3.8 million SWU of production
        based on current estimates of machine output and plant
        availability. The American Centrifuge technology is modular by
        design and plant output can be expanded. The NRC's May 2006
        Environmental Impact Statement evaluated the modular expansion
        of the plant to about double its currently planned production
        capability.

    --  The Lead Cascade of American Centrifuge machines is currently
        being assembled and installed at the plant in Piketon, Ohio.
        The Lead Cascade is the first group of centrifuges working
        together to enrich uranium to commercial grade concentration
        of U-235. The Lead Cascade is expected to be operational in
        mid-2007.

    --  In March 2007, DOE accepted our proposal that completion dates
        for two project milestones be rescheduled. The October 2006
        milestone related to Lead Cascade operations has been revised
        to: October 2007 - Lead Cascade operational and generating
        product assay in a range usable by commercial nuclear power
        plants. The January 2007 milestone requiring us to have
        secured a financing commitment for a 1 million SWU centrifuge
        plant has been rescheduled to January 2008. Under our revised
        deployment schedule, we are working toward beginning
        commercial plant operations of the American Centrifuge Plant
        in late-2009 and having approximately 11,500 machines deployed
        in 2012, which we expect to operate at a production rate of
        about 3.8 million SWU per year based on our current estimates
        of machine output and plant availability. This revised
        schedule is about a year later than the schedule established
        by the milestones contained in the DOE-USEC Agreement and USEC
        anticipates reaching agreement with DOE regarding these
        milestones at a later date.

    --  The Company is working to obtain some form of investment or
        other participation by a third party and/or the U.S.
        government to raise the capital needed to finance construction
        of the American Centrifuge Plant. Our target estimate for the
        cost of deployment of the American Centrifuge Plant is $2.3
        billion in nominal dollars, including amounts already spent
        and not including costs of financing or a reserve for general
        contingencies. We expect to spend approximately $340 million
        on the project in 2007. The rate of planned investment will
        increase substantially after 2007 under our deployment
        schedule, with spending in 2008 currently projected to be
        about double the level of 2007.

    --  USEC has been discussing with DOE the potential for USEC to
        re-enrich uranium contained in cylinders of depleted uranium,
        also known as "tails." These tails have relatively high assays
        of U-235 content and were generated by the U.S. government
        when it operated gaseous diffusion plants in Kentucky, Ohio
        and Tennessee. These cylinders are owned by the U.S.
        government and are being held as a liability pending their
        ultimate disposal. Because the market price of uranium has
        increased dramatically over the past three years, it now makes
        economic sense to reclaim more of the U-235 content remaining
        in these byproduct cylinders. USEC has the only domestic
        enrichment plant capable of processing and reclaiming the
        U-235 content from these cylinders, so we believe USEC is
        ideally suited to this task. The Company has been discussing
        with DOE the potential for USEC to re-enrich the uranium
        contained in these cylinders for the benefit of USEC, its
        customers and the U.S. government. Any agreement for the
        re-enrichment of DOE's tails will require action by the U.S.
        government, and the nature and the timing of any action is
        uncertain.

    --  USEC has also submitted a pre-application for a loan guarantee
        under the DOE's loan guarantee program. It is a competitive
        process but we believe USEC is well qualified for loan
        guarantees under criteria for both energy conservation and
        nuclear power. However, the program is still being established
        and additional funding will be required for any meaningful
        loan guarantees to be offered. USEC does not expect to hear
        about potential awards before late 2007 or early 2008.

USEC Inc., a global energy company, is a leading supplier of enriched uranium fuel for commercial nuclear power plants.

Use of Non-GAAP Financial Information

The earnings release contains a non-GAAP financial measure - pro forma net income before American Centrifuge expenses. Management believes that, because pro forma net income before American Centrifuge expenses excludes the significant expenses related to the Company's development of the American Centrifuge uranium enrichment technology, which is not the technology the Company now uses in its uranium enrichment operations, it is more reflective of the Company's current core operating results and provides investors with additional useful information to measure the Company's performance, particularly with respect to performance from period to period.

While the Company believes this non-GAAP financial measure is useful in evaluating the Company, the information should be considered as supplemental in nature and not as a substitute for or superior to the related financial information prepared in accordance with GAAP.

Forward Looking Statements

This document contains "forward-looking statements" - that is, statements related to future events. In this context, forward-looking statements may address our expected future business and financial performance, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "will" and other words of similar meaning. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. For USEC, particular risks and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements include, but are not limited to: the success of the demonstration and deployment of our American Centrifuge technology including our ability to meet our target cost estimate and schedule for the American Centrifuge Plant and our ability to secure required external financial support; the cost of electric power used at our gaseous diffusion plant; our dependence on deliveries under the Russian Contract and on a single production facility; changes in existing restrictions on imports of Russian enriched uranium, including the imposition of duties on imports of enriched uranium under the Russian Contract; the elimination of duties charged on imports of foreign-produced low enriched uranium; pricing trends in the uranium and enrichment markets and their impact on our profitability and the price we pay for enriched uranium under the Russian Contract; changes to, or termination of, our contracts with the U.S. government and changes in U.S. government priorities and the availability of government funding; the impact of government regulation; the outcome of legal proceedings and other contingencies (including lawsuits, government investigations or audits and government/regulatory and environmental remediation efforts); the competitive environment for our products and services; changes in the nuclear energy industry; and other risks and uncertainties discussed in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K and subsequent quarterly Form 10-Qs. Revenue and operating results can fluctuate significantly from quarter to quarter, and in some cases, year to year. We do not undertake to update our forward-looking statements except as required by law.

                              USEC Inc.
        RECONCILIATION OF NON-GAAP PRO FORMA NET INCOME BEFORE
     AMERICAN CENTRIFUGE EXPENSES TO GAAP NET INCOME (Unaudited)

                                                         Three Months
                                                             Ended
Amounts in millions                                        March 31,
                                                         -------------
                                                          2007   2006
                                                         ------ ------
Pro forma net income before American Centrifuge expenses $61.0  $47.3

 LESS: American Centrifuge expenses (a)                   33.4   19.5
 ADD: Provision for income taxes (based on Federal
  statutory tax rate of 35%) (b)                         (11.7)  (6.8)
                                                         ------ ------
  SUBTOTAL: American Centrifuge expenses, net of taxes   $21.7  $12.7

Net income, GAAP basis                                   $39.3  $34.6
                                                         ====== ======

Note (a): American Centrifuge expenses included in Advanced technology
 costs.
Note (b): Based on our anticipated earnings for 2007 and recent
 changes in state tax laws, USEC expects the effective tax rate in
 2007 to be in the range of 15 to 20 percent.
                              USEC Inc.
       CONSOLIDATED CONDENSED STATEMENTS OF INCOME (Unaudited)
                  (millions, except per share data)

                                                   Three Months Ended
                                                       March 31,
                                                  --------------------
                                                    2007       2006
                                                  ---------  ---------
Revenue:
  Separative work units                             $405.0     $234.0
  Uranium                                             15.8       75.8
  U.S. government contracts and other                 44.2       51.5
                                                  ---------  ---------
  Total revenue                                      465.0      361.3
Cost of sales:
  Separative work units and uranium                  353.2      225.7
  U.S. government contracts and other                 38.6       43.6
                                                  ---------  ---------
  Total cost of sales                                391.8      269.3
                                                  ---------  ---------
Gross profit                                          73.2       92.0
Special charge for organizational restructuring          -        1.5
Advanced technology costs                             33.7       19.8
Selling, general and administrative                   12.5       11.7
                                                  ---------  ---------
Operating income                                      27.0       59.0
Interest expense                                       3.5        4.7
Interest (income)                                     (9.9)      (1.8)
                                                  ---------  ---------
Income before income taxes                            33.4       56.1
Provision (benefit) for income taxes                  (5.9)      21.5
                                                  ---------  ---------
Net income                                           $39.3      $34.6
                                                  =========  =========
Net income per share - basic and diluted              $.45       $.40
Weighted-average number of shares outstanding:
    Basic                                             86.8       86.3
    Diluted                                           87.2       86.6
                              USEC Inc.
          CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited)
                              (millions)

                                              March 31,   December 31,
                                                 2007         2006
                                             ------------ ------------
ASSETS
Current Assets
  Cash and cash equivalents                       $238.6       $171.4
  Accounts receivable - trade                      175.4        215.9
  Inventories                                    1,008.1        900.0
  Deferred income taxes                             26.0         24.0
  Other current assets                              91.0         97.8
                                             ------------ ------------
  Total Current Assets                           1,539.1      1,409.1
Property, Plant and Equipment, net                 192.0        189.9
Other Long-Term Assets
  Deferred income taxes                            187.8        156.2
  Deposits for surety bonds                         65.2         60.8
  Pension asset                                     15.7         13.8
  Inventories                                          -         24.2
  Goodwill                                           6.8          6.8
     Intangibles                                     0.5          0.6
                                             ------------ ------------
  Total Other Long-Term Assets                     276.0        262.4
                                             ------------ ------------
Total Assets                                    $2,007.1     $1,861.4
                                             ============ ============

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
  Short-term debt                                   $0.1           $-
  Accounts payable and accrued liabilities         138.6        129.1
  Payables under Russian Contract                  114.7        105.3
  Inventories owed to customers and suppliers      118.7         56.9
  Deferred revenue and advances from
   customers                                       150.6        133.8
                                             ------------ ------------
  Total Current Liabilities                        522.7        425.1
Long-Term Debt                                     150.0        150.0
Other Long-Term Liabilities
  Depleted uranium disposition                      78.4         71.5
  Postretirement health and life benefit
   obligations                                     130.6        128.7
  Pension benefit liabilities                       21.0         20.2
  Other liabilities                                 98.4         79.9
                                             ------------ ------------
  Total Other Long-Term Liabilities                328.4        300.3
Stockholders' Equity                             1,006.0        986.0
                                             ------------ ------------
Total Liabilities and Stockholders' Equity      $2,007.1     $1,861.4
                                             ============ ============
                              USEC Inc.
     CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)
                              (millions)

                                                   Three Months Ended
                                                       March 31,
                                                  --------------------
                                                    2007       2006
                                                  ---------  ---------
Cash Flows from Operating Activities
Net income                                           $39.3      $34.6
Adjustments to reconcile net income to net cash
 provided by operating activities:
  Depreciation and amortization                        9.1        9.0
  Deferred income taxes                               (9.1)       5.4
  Changes in operating assets and liabilities:
     Accounts receivable - decrease                   40.5       60.0
     Inventories - net (increase)                    (22.1)      (3.0)
     Payables under Russian Contract - increase
      (decrease)                                       9.4      (33.2)
     Deferred revenue, net of deferred costs -
      increase (decrease)                             22.6      (10.5)
     Accrued depleted uranium disposition              6.9        4.3
     Accounts payable and other liabilities -
      (decrease)                                      (9.7)     (31.7)
     Other, net                                        0.6        2.2
                                                  ---------  ---------
Net Cash Provided by Operating Activities             87.5       37.1
                                                  ---------  ---------

Cash Flows Used in Investing Activities
Capital expenditures                                 (16.1)      (7.5)
Deposits for surety bonds                             (4.0)         -
                                                  ---------  ---------
Net Cash (Used in) Investing Activities              (20.1)      (7.5)
                                                  ---------  ---------

Cash Flows Used in Financing Activities
Borrowings under credit facility                       1.1       99.0
Repayments under credit facility                      (1.0)     (78.5)
Repayment of senior notes                                -     (288.8)
Tax benefit related to stock-based compensation        0.3        0.3
Common stock issued (purchased), net                  (0.6)       0.9
                                                  ---------  ---------
Net Cash (Used in) Financing Activities               (0.2)    (267.1)
                                                  ---------  ---------
Net Increase (Decrease)                               67.2     (237.5)
Cash and Cash Equivalents at Beginning of Period     171.4      259.1
                                                  ---------  ---------
Cash and Cash Equivalents at End of Period          $238.6      $21.6
                                                  =========  =========
Supplemental Cash Flow Information:
  Interest paid                                       $4.5      $14.8
  Income taxes paid                                    2.9       22.9

CONTACT: USEC Inc.
Investors: Steven Wingfield, 301-564-3354
Media: Elizabeth Stuckle, 301-564-3399

SOURCE: USEC Inc.